Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MeridianLink | MLNK | Jan 14, 2025 | 18.95 | -0.32 |
Merit Medical Systems | MMSI | Jan 14, 2025 | 99.89 | +4.44 |
Meritage Homes | MTH | Jan 14, 2025 | 78.52 | +3.79 |
Merrill Lynch & Co. | IPB | Jan 14, 2025 | 25.50 | +0.29 |
Mersana Therapeutics | MRSN | Jan 14, 2025 | 0.63 | +2.01 |
Merus N.V | MRUS | Jan 14, 2025 | 39.01 | -3.57 |
Mesa Air Group | MESA | Jan 14, 2025 | 1.34 | -0.74 |
Mesa Laboratories | MLAB | Jan 14, 2025 | 131.05 | -0.04 |
Mesa Royalty Trust | MTR | Jan 14, 2025 | 6.47 | -0.31 |
Mesabi Royalty Trust | MSB | Jan 14, 2025 | 26.74 | -0.52 |
Mesoblast ADR | MESO | Jan 14, 2025 | 16.98 | -1.16 |
Meta Platforms A | META | Jan 14, 2025 | 594.25 | -2.31 |
Metagenomi | MGX | Jan 14, 2025 | 2.76 | -5.15 |
Metal Sky Star Acquisition | MSSA | Jan 14, 2025 | 11.63 | 0.00 |
Metalla Royalty & Streaming | MTA | Jan 14, 2025 | 2.66 | +5.14 |
Metallus | MTUS | Jan 14, 2025 | 14.37 | +1.05 |
MetaVia | MTVA | Jan 14, 2025 | 2.04 | 0.00 |
Methalpa Technology Holding | MATH | Jan 14, 2025 | 1.52 | +3.44 |
Methanex | MEOH | Jan 14, 2025 | 49.47 | +2.96 |
Methode Electronics | MEI | Jan 14, 2025 | 11.73 | +2.09 |
MetLife | MET | Jan 14, 2025 | 83.83 | +2.34 |
Metlife Pref A | MET-A | Jan 14, 2025 | 25.00 | +0.52 |
Metlife Pref E | MET-E | Jan 14, 2025 | 23.03 | +0.39 |
Metlife Pref F | MET-F | Jan 14, 2025 | 20.07 | +0.55 |
MetroCity Bankshares | MCBS | Jan 14, 2025 | 31.24 | +3.51 |
Metropolitan Bank | MCB | Jan 14, 2025 | 59.43 | +3.32 |
Mettler-Toledo International | MTD | Jan 14, 2025 | 1 271.36 | +0.33 |
Mexco Energy | MXC | Jan 14, 2025 | 12.61 | -4.72 |
Mexico Equity And Income Fund | MXE | Jan 14, 2025 | 8.14 | -0.04 |
Mexico Fund | MXF | Jan 14, 2025 | 13.44 | +0.75 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.